S1PR1 and myeloid sarcoma: In particular, S1P1 is thought to be mechanistically important in MS in that a functional antagonism of S1P1 reduces lymphocyte egress from secondary lymphoid organs, resulting in a decreased number of pathogenic lymphocytes entering the CNS (Mandala et al., 2002; Arnon et al., 2011).